Dr. Cassady is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
555 S 18th St
Columbus, OH 43205Phone+1 614-722-6200Fax+1 614-722-4565
Education & Training
- University of WashingtonResidency, Pediatrics, 1991 - 1994
- University of Alabama School of MedicineClass of 1991
Certifications & Licensure
- ID State Medical License 1993 - Present
- OR State Medical License 1994 - Present
- OH State Medical License 2015 - 2025
- AL State Medical License 1995 - 2015
- WA State Medical License 1991 - 1995
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.Yeaseul Kim, Uksha Saini, Doyeon Kim, Ilse Hernandez-Aguirre, Jack Hedberg
Frontiers in Immunology. 2024-01-01 - 5 citationsOpportunities and challenges of combining adoptive cellular therapy with oncolytic virotherapy.Joseph A Mamola, Chun-Yu Chen, Mark A Currier, Kevin Cassady, Dean A Lee
Molecular Therapy Oncolytics. 2023-06-15 - 17 citationsImmune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.Katherine E Miller, Kevin A Cassady, Justin C Roth, Jennifer Clements, Kathleen M Schieffer
Clinical Cancer Research. 2022-02-01
Press Mentions
- Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022March 9th, 2022
- Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022March 9th, 2022
- Study Supports Virotherapy as a Potential Treatment for Brain TumorsFebruary 1st, 2022
- Join now to see all
Grant Support
- HSV US11 Mediated Evasion Of Host ShutoffNational Institute Of Allergy And Infectious Diseases2000–2001
- HSV-1 US11 Mediated Evasion Of Host ShutoffNational Institute Of Allergy And Infectious Diseases1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: